Evidence map›Paper›PMID 38674367›Full record

ArticleGenes2024

Gene Dosage of

Donato Gemmati, Elisabetta D'Aversa, Bianca Antonica, Miriana Grisafi, Francesca Salvatori, Stefano Pizzicotti, Patrizia Pellegatti, Maria Ciccone, Stefano Moratelli, Maria Luisa Serino and 1 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Donato GemmatiDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-6213-6120
Elisabetta D'AversaDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0003-3058-5866
Bianca AntonicaDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0009-0003-1153-2643
Miriana GrisafiDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Francesca SalvatoriDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-8950-9978
Stefano PizzicottiHospital-University of Ferrara, 44121 Ferrara, Italy.
Patrizia PellegattiHospital-University of Ferrara, 44121 Ferrara, Italy.
Maria CicconeHaematology Unit, Hospital-University of Ferrara, 44121 Ferrara, Italy.
Stefano MoratelliCentre Haemostasis & Thrombosis, University of Ferrara, 44121 Ferrara, Italy.
Maria Luisa SerinoCentre Haemostasis & Thrombosis, University of Ferrara, 44121 Ferrara, Italy.
Veronica TisatoDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-8448-066X
University of Ferrara · IT

Funding

University of Ferrara FAR and FIRD
6 · The paper itself

Abstract

Inherited defects in the genes of blood coagulation essentially express the severity of the clinical phenotype that is directly correlated to the number of mutated alleles of the candidate leader gene (e.g., heterozygote vs. homozygote) and of possible additional coinherited traits. The

Indexed as

Factor VHemorrhagePhenotypeThrombosisAdultCodon, TerminatorFemaleGene DosageHeterozygoteHumansMalePedigreeCodon, TerminatorFactor Vblood coagulationcis-segregationFV Leideninherited thrombophiliapremature stop-codon (PTC)readthrough

Identifiers

PMID38674367
PMCPMC11050146
OpenAlexW4393317383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.